Stock listing

UPB Stock Price, News, Filings & Events — Upstream Bio, Inc.

Selected listing: UPB · BOATS · USD · US

This page tracks Upstream Bio, Inc.'s UPB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UPB:BOATS. UPB:BOATS is the stock-level entry point for investors researching Upstream Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Upstream Bio, Inc. is a public company traded under the ticker UPB in the American market. With a market capitalization of approximately $348.8 million, the company is focused on advancing its biotechnology initiatives. Investors can find detailed information about its operations and performance on its public company page.

UPB:BOATSUSDUSUpdated September 11, 2026
Upstream Bio, Inc. logo
Ticker
UPB:BOATS
Asset type
Stock
Market cap
$313.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Upstream Bio, Inc. UPB:BOATS stock context

This page tracks Upstream Bio, Inc.'s UPB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UPB:BOATS. UPB:BOATS is the stock-level entry point for investors researching Upstream Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Upstream Bio, Inc. is a public company traded under the ticker UPB in the American market. With a market capitalization of approximately $348.8 million, the company is focused on advancing its biotechnology initiatives. Investors can find detailed information about its operations and performance on its public company page.

Latest news from Upstream Bio, Inc.

All Upstream Bio, Inc. news →

Research Upstream Bio, Inc.

Alternate listings